US Patent Issued to Board of Regents, The University of Texas System on Oct. 20 for "Methods for treatment of cancers with EGFR activating mutations" (Texas Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,144, issued on Oct. 20, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Methods for treatment of cancers with EGFR activating mutations" was invented by John V. Heymach (Houston), Monique Nilsson (Houston) and Jacqulyne Robichaux (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for treating cancer in a patient determined to have an EGFR activating mutation by administering a CDK inhibitor and/or SAC component inhibitor."

The patent was filed on March 13, 2019, under Application No. 16/980,079.

*For further information, including images, charts and tables, please visi...